Protein Never in Mitosis Gene A Interacting-1 regulates calpain activity and the degradation of cyclooxygenase-2 in endothelial cells View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2009-06-22

AUTHORS

Tongzheng Liu, Ryan A Schneider, Vaibhav Shah, Yongcheng Huang, Rostislav I Likhotvorik, Lakhu Keshvara, Dale G Hoyt

ABSTRACT

BackgroundThe peptidyl-proline isomerase, Protein Never in Mitosis Gene A Interacting-1 (PIN1), regulates turnover of inducible nitric oxide synthase (iNOS) in murine aortic endothelial cells (MAEC) stimulated with E. coli endotoxin (LPS) and interferon-γ (IFN). Degradation of iNOS was reduced by a calpain inhibitor, suggesting that PIN1 may affect induction of other calpain-sensitive inflammatory proteins, such as cyclooxygenase (COX)-2, in MAEC.MethodsMAEC, transduced with lentivirus encoding an inactive control short hairpin (sh) RNA or one targeting PIN1 that reduced PIN1 by 85%, were used. Cells were treated with LPS/IFN, calpain inhibitors (carbobenzoxy-valinyl-phenylalaninal (zVF), PD150606), cycloheximide and COX inhibitors to determine the effect of PIN1 depletion on COX-2 and calpain.ResultsLPS or IFN alone did not induce COX-2. However, treatment with 10 μg LPS plus 20 ng IFN per ml induced COX-2 protein 10-fold in Control shRNA MAEC. Induction was significantly greater (47-fold) in PIN1 shRNA cells. COX-2-dependent prostaglandin E2 production increased 3-fold in KD MAEC, but did not increase in Control cells. The additional increase in COX-2 protein due to PIN1 depletion was post-transcriptional, as induction of COX-2 mRNA by LPS/IFN was the same in cells containing or lacking PIN1. Instead, the loss of COX-2 protein, after treatment with cycloheximide to block protein synthesis, was reduced in cells lacking PIN1 in comparison with Control cells, indicating that degradation of the enzyme was reduced. zVF and PD150606 each enhanced the induction of COX-2 by LPS/IFN. zVF also slowed the loss of COX-2 after treatment with cycloheximide, and COX-2 was degraded by exogenous μ-calpain in vitro. In contrast to iNOS, physical interaction between COX-2 and PIN1 was not detected, suggesting that effects of PIN1 on calpain, rather than COX-2 itself, affect COX-2 degradation. While cathepsin activity was unaltered, depletion of PIN1 reduced calpain activity by 55% in comparison with Control shRNA cells.ConclusionPIN1 reduced calpain activity and slowed the degradation of COX-2 in MAEC, an effect recapitulated by an inhibitor of calpain. Given the sensitivity of COX-2 and iNOS to calpain, PIN1 may normally limit induction of these and other calpain substrates by maintaining calpain activity in endothelial cells. More... »

PAGES

20

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1476-9255-6-20

DOI

http://dx.doi.org/10.1186/1476-9255-6-20

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1019519993

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19545424


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Pharmacology, The Ohio State University College of Pharmacy, and The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, Ohio, USA", 
          "id": "http://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "Division of Pharmacology, The Ohio State University College of Pharmacy, and The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, Ohio, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Tongzheng", 
        "id": "sg:person.01362107006.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362107006.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Pharmacology, The Ohio State University College of Pharmacy, and The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, Ohio, USA", 
          "id": "http://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "Division of Pharmacology, The Ohio State University College of Pharmacy, and The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, Ohio, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schneider", 
        "givenName": "Ryan A", 
        "id": "sg:person.01005121506.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005121506.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Pharmacology, The Ohio State University College of Pharmacy, and The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, Ohio, USA", 
          "id": "http://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "Division of Pharmacology, The Ohio State University College of Pharmacy, and The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, Ohio, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shah", 
        "givenName": "Vaibhav", 
        "id": "sg:person.0640400712.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640400712.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular Genetics, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, 75390, Dallas, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.267313.2", 
          "name": [
            "Division of Pharmacology, The Ohio State University College of Pharmacy, and The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, Ohio, USA", 
            "Department of Molecular Genetics, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, 75390, Dallas, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huang", 
        "givenName": "Yongcheng", 
        "id": "sg:person.0752121645.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752121645.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Pharmacology, The Ohio State University College of Pharmacy, and The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, Ohio, USA", 
          "id": "http://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "Division of Pharmacology, The Ohio State University College of Pharmacy, and The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, Ohio, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Likhotvorik", 
        "givenName": "Rostislav I", 
        "id": "sg:person.01020235045.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020235045.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Pharmacology, The Ohio State University College of Pharmacy, and The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, Ohio, USA", 
          "id": "http://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "Division of Pharmacology, The Ohio State University College of Pharmacy, and The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, Ohio, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Keshvara", 
        "givenName": "Lakhu", 
        "id": "sg:person.0701766503.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701766503.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Pharmacology, The Ohio State University College of Pharmacy, and The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, Ohio, USA", 
          "id": "http://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "Division of Pharmacology, The Ohio State University College of Pharmacy, and The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, Ohio, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hoyt", 
        "givenName": "Dale G", 
        "id": "sg:person.01242743756.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242743756.91"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1290/1543-706x(2003)039<0043:aenmfi>2.0.co;2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011407638", 
          "https://doi.org/10.1290/1543-706x(2003)039<0043:aenmfi>2.0.co;2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1476-9255-4-22", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037556817", 
          "https://doi.org/10.1186/1476-9255-4-22"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncb0901-793", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006140773", 
          "https://doi.org/10.1038/ncb0901-793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11259-007-9001-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053416274", 
          "https://doi.org/10.1007/s11259-007-9001-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrm2261", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043505520", 
          "https://doi.org/10.1038/nrm2261"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-06-22", 
    "datePublishedReg": "2009-06-22", 
    "description": "BackgroundThe peptidyl-proline isomerase, Protein Never in Mitosis Gene A Interacting-1 (PIN1), regulates turnover of inducible nitric oxide synthase (iNOS) in murine aortic endothelial cells (MAEC) stimulated with E. coli endotoxin (LPS) and interferon-\u03b3 (IFN). Degradation of iNOS was reduced by a calpain inhibitor, suggesting that PIN1 may affect induction of other calpain-sensitive inflammatory proteins, such as cyclooxygenase (COX)-2, in MAEC.MethodsMAEC, transduced with lentivirus encoding an inactive control short hairpin (sh) RNA or one targeting PIN1 that reduced PIN1 by 85%, were used. Cells were treated with LPS/IFN, calpain inhibitors (carbobenzoxy-valinyl-phenylalaninal (zVF), PD150606), cycloheximide and COX inhibitors to determine the effect of PIN1 depletion on COX-2 and calpain.ResultsLPS or IFN alone did not induce COX-2. However, treatment with 10 \u03bcg LPS plus 20 ng IFN per ml induced COX-2 protein 10-fold in Control shRNA MAEC. Induction was significantly greater (47-fold) in PIN1 shRNA cells. COX-2-dependent prostaglandin E2 production increased 3-fold in KD MAEC, but did not increase in Control cells. The additional increase in COX-2 protein due to PIN1 depletion was post-transcriptional, as induction of COX-2 mRNA by LPS/IFN was the same in cells containing or lacking PIN1. Instead, the loss of COX-2 protein, after treatment with cycloheximide to block protein synthesis, was reduced in cells lacking PIN1 in comparison with Control cells, indicating that degradation of the enzyme was reduced. zVF and PD150606 each enhanced the induction of COX-2 by LPS/IFN. zVF also slowed the loss of COX-2 after treatment with cycloheximide, and COX-2 was degraded by exogenous \u03bc-calpain in vitro. In contrast to iNOS, physical interaction between COX-2 and PIN1 was not detected, suggesting that effects of PIN1 on calpain, rather than COX-2 itself, affect COX-2 degradation. While cathepsin activity was unaltered, depletion of PIN1 reduced calpain activity by 55% in comparison with Control shRNA cells.ConclusionPIN1 reduced calpain activity and slowed the degradation of COX-2 in MAEC, an effect recapitulated by an inhibitor of calpain. Given the sensitivity of COX-2 and iNOS to calpain, PIN1 may normally limit induction of these and other calpain substrates by maintaining calpain activity in endothelial cells.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1476-9255-6-20", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1034480", 
        "issn": [
          "1078-7852", 
          "1476-9255"
        ], 
        "name": "Journal of Inflammation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "6"
      }
    ], 
    "keywords": [
      "inducible nitric oxide synthase", 
      "COX-2 protein", 
      "LPS/IFN", 
      "murine aortic endothelial cells", 
      "COX-2", 
      "calpain activity", 
      "endothelial cells", 
      "shRNA cells", 
      "calpain inhibitors", 
      "control shRNA cells", 
      "nitric oxide synthase", 
      "E. coli endotoxin", 
      "Pin1 depletion", 
      "prostaglandin E2 production", 
      "control cells", 
      "COX-2 mRNA", 
      "control short hairpin RNA", 
      "mitosis gene", 
      "COX-2 degradation", 
      "aortic endothelial cells", 
      "short hairpin RNA", 
      "effect of Pin1", 
      "inflammatory protein", 
      "COX inhibitors", 
      "oxide synthase", 
      "inhibitor of calpain", 
      "cyclooxygenase-2", 
      "E2 production", 
      "coli endotoxin", 
      "peptidyl-proline isomerase", 
      "depletion of Pin1", 
      "IFN", 
      "calpain substrates", 
      "hairpin RNA", 
      "cathepsin activity", 
      "inhibitors", 
      "treatment", 
      "induction", 
      "calpain", 
      "Pin1", 
      "protein synthesis", 
      "cells", 
      "\u03bc-calpain", 
      "protein", 
      "physical interaction", 
      "cycloheximide", 
      "additional increase", 
      "genes", 
      "ResultsLPS", 
      "depletion", 
      "interferon", 
      "cyclooxygenase", 
      "activity", 
      "LPS", 
      "endotoxin", 
      "lentivirus", 
      "PD150606", 
      "effect", 
      "degradation", 
      "mRNA", 
      "loss", 
      "isomerase", 
      "synthase", 
      "RNA", 
      "enzyme", 
      "turnover", 
      "sensitivity", 
      "increase", 
      "contrast", 
      "comparison", 
      "production", 
      "substrate", 
      "interaction", 
      "synthesis"
    ], 
    "name": "Protein Never in Mitosis Gene A Interacting-1 regulates calpain activity and the degradation of cyclooxygenase-2 in endothelial cells", 
    "pagination": "20", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1019519993"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1476-9255-6-20"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19545424"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1476-9255-6-20", 
      "https://app.dimensions.ai/details/publication/pub.1019519993"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_493.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1476-9255-6-20"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1476-9255-6-20'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1476-9255-6-20'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1476-9255-6-20'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1476-9255-6-20'


 

This table displays all metadata directly associated to this object as RDF triples.

205 TRIPLES      21 PREDICATES      105 URIs      91 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1476-9255-6-20 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 anzsrc-for:1115
4 schema:author Nad57d292c61947a3968df96b3d46d29a
5 schema:citation sg:pub.10.1007/s11259-007-9001-2
6 sg:pub.10.1038/ncb0901-793
7 sg:pub.10.1038/nrm2261
8 sg:pub.10.1186/1476-9255-4-22
9 sg:pub.10.1290/1543-706x(2003)039<0043:aenmfi>2.0.co;2
10 schema:datePublished 2009-06-22
11 schema:datePublishedReg 2009-06-22
12 schema:description BackgroundThe peptidyl-proline isomerase, Protein Never in Mitosis Gene A Interacting-1 (PIN1), regulates turnover of inducible nitric oxide synthase (iNOS) in murine aortic endothelial cells (MAEC) stimulated with E. coli endotoxin (LPS) and interferon-γ (IFN). Degradation of iNOS was reduced by a calpain inhibitor, suggesting that PIN1 may affect induction of other calpain-sensitive inflammatory proteins, such as cyclooxygenase (COX)-2, in MAEC.MethodsMAEC, transduced with lentivirus encoding an inactive control short hairpin (sh) RNA or one targeting PIN1 that reduced PIN1 by 85%, were used. Cells were treated with LPS/IFN, calpain inhibitors (carbobenzoxy-valinyl-phenylalaninal (zVF), PD150606), cycloheximide and COX inhibitors to determine the effect of PIN1 depletion on COX-2 and calpain.ResultsLPS or IFN alone did not induce COX-2. However, treatment with 10 μg LPS plus 20 ng IFN per ml induced COX-2 protein 10-fold in Control shRNA MAEC. Induction was significantly greater (47-fold) in PIN1 shRNA cells. COX-2-dependent prostaglandin E2 production increased 3-fold in KD MAEC, but did not increase in Control cells. The additional increase in COX-2 protein due to PIN1 depletion was post-transcriptional, as induction of COX-2 mRNA by LPS/IFN was the same in cells containing or lacking PIN1. Instead, the loss of COX-2 protein, after treatment with cycloheximide to block protein synthesis, was reduced in cells lacking PIN1 in comparison with Control cells, indicating that degradation of the enzyme was reduced. zVF and PD150606 each enhanced the induction of COX-2 by LPS/IFN. zVF also slowed the loss of COX-2 after treatment with cycloheximide, and COX-2 was degraded by exogenous μ-calpain in vitro. In contrast to iNOS, physical interaction between COX-2 and PIN1 was not detected, suggesting that effects of PIN1 on calpain, rather than COX-2 itself, affect COX-2 degradation. While cathepsin activity was unaltered, depletion of PIN1 reduced calpain activity by 55% in comparison with Control shRNA cells.ConclusionPIN1 reduced calpain activity and slowed the degradation of COX-2 in MAEC, an effect recapitulated by an inhibitor of calpain. Given the sensitivity of COX-2 and iNOS to calpain, PIN1 may normally limit induction of these and other calpain substrates by maintaining calpain activity in endothelial cells.
13 schema:genre article
14 schema:isAccessibleForFree true
15 schema:isPartOf Nbeb4a673af514c2699c809d80844931b
16 Nf729c2181a4b4b4d9427a68df1f946e6
17 sg:journal.1034480
18 schema:keywords COX inhibitors
19 COX-2
20 COX-2 degradation
21 COX-2 mRNA
22 COX-2 protein
23 E. coli endotoxin
24 E2 production
25 IFN
26 LPS
27 LPS/IFN
28 PD150606
29 Pin1
30 Pin1 depletion
31 RNA
32 ResultsLPS
33 activity
34 additional increase
35 aortic endothelial cells
36 calpain
37 calpain activity
38 calpain inhibitors
39 calpain substrates
40 cathepsin activity
41 cells
42 coli endotoxin
43 comparison
44 contrast
45 control cells
46 control shRNA cells
47 control short hairpin RNA
48 cycloheximide
49 cyclooxygenase
50 cyclooxygenase-2
51 degradation
52 depletion
53 depletion of Pin1
54 effect
55 effect of Pin1
56 endothelial cells
57 endotoxin
58 enzyme
59 genes
60 hairpin RNA
61 increase
62 inducible nitric oxide synthase
63 induction
64 inflammatory protein
65 inhibitor of calpain
66 inhibitors
67 interaction
68 interferon
69 isomerase
70 lentivirus
71 loss
72 mRNA
73 mitosis gene
74 murine aortic endothelial cells
75 nitric oxide synthase
76 oxide synthase
77 peptidyl-proline isomerase
78 physical interaction
79 production
80 prostaglandin E2 production
81 protein
82 protein synthesis
83 sensitivity
84 shRNA cells
85 short hairpin RNA
86 substrate
87 synthase
88 synthesis
89 treatment
90 turnover
91 μ-calpain
92 schema:name Protein Never in Mitosis Gene A Interacting-1 regulates calpain activity and the degradation of cyclooxygenase-2 in endothelial cells
93 schema:pagination 20
94 schema:productId N754315296225403f98c53b775459d5bd
95 Nde6e3bfb857746b484922c2ece0c9551
96 Nef39f1091b254331b85250315c805102
97 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019519993
98 https://doi.org/10.1186/1476-9255-6-20
99 schema:sdDatePublished 2022-11-24T20:54
100 schema:sdLicense https://scigraph.springernature.com/explorer/license/
101 schema:sdPublisher N4917a98ca7684628b1e528cc22ce05d7
102 schema:url https://doi.org/10.1186/1476-9255-6-20
103 sgo:license sg:explorer/license/
104 sgo:sdDataset articles
105 rdf:type schema:ScholarlyArticle
106 N29fa484c719e4e8e92532fb24047c019 rdf:first sg:person.0752121645.38
107 rdf:rest Nd10120b98dc3443595c1a7022ca0b08c
108 N4917a98ca7684628b1e528cc22ce05d7 schema:name Springer Nature - SN SciGraph project
109 rdf:type schema:Organization
110 N754315296225403f98c53b775459d5bd schema:name dimensions_id
111 schema:value pub.1019519993
112 rdf:type schema:PropertyValue
113 N820d16937cc847a49be1791ac0ec5ff7 rdf:first sg:person.0640400712.03
114 rdf:rest N29fa484c719e4e8e92532fb24047c019
115 N8b070d5a76394c9ea2b81d7d0a8b259e rdf:first sg:person.01005121506.77
116 rdf:rest N820d16937cc847a49be1791ac0ec5ff7
117 Nad57d292c61947a3968df96b3d46d29a rdf:first sg:person.01362107006.03
118 rdf:rest N8b070d5a76394c9ea2b81d7d0a8b259e
119 Nbeb4a673af514c2699c809d80844931b schema:volumeNumber 6
120 rdf:type schema:PublicationVolume
121 Nd10120b98dc3443595c1a7022ca0b08c rdf:first sg:person.01020235045.25
122 rdf:rest Nf9f67adecb6742a5a2b5d93be22db4cc
123 Nde6e3bfb857746b484922c2ece0c9551 schema:name doi
124 schema:value 10.1186/1476-9255-6-20
125 rdf:type schema:PropertyValue
126 Nef39f1091b254331b85250315c805102 schema:name pubmed_id
127 schema:value 19545424
128 rdf:type schema:PropertyValue
129 Nf0cdb7836d314eb0b299d1aa00c9ebc1 rdf:first sg:person.01242743756.91
130 rdf:rest rdf:nil
131 Nf729c2181a4b4b4d9427a68df1f946e6 schema:issueNumber 1
132 rdf:type schema:PublicationIssue
133 Nf9f67adecb6742a5a2b5d93be22db4cc rdf:first sg:person.0701766503.35
134 rdf:rest Nf0cdb7836d314eb0b299d1aa00c9ebc1
135 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
136 schema:name Medical and Health Sciences
137 rdf:type schema:DefinedTerm
138 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
139 schema:name Clinical Sciences
140 rdf:type schema:DefinedTerm
141 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
142 schema:name Pharmacology and Pharmaceutical Sciences
143 rdf:type schema:DefinedTerm
144 sg:journal.1034480 schema:issn 1078-7852
145 1476-9255
146 schema:name Journal of Inflammation
147 schema:publisher Springer Nature
148 rdf:type schema:Periodical
149 sg:person.01005121506.77 schema:affiliation grid-institutes:grid.261331.4
150 schema:familyName Schneider
151 schema:givenName Ryan A
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005121506.77
153 rdf:type schema:Person
154 sg:person.01020235045.25 schema:affiliation grid-institutes:grid.261331.4
155 schema:familyName Likhotvorik
156 schema:givenName Rostislav I
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020235045.25
158 rdf:type schema:Person
159 sg:person.01242743756.91 schema:affiliation grid-institutes:grid.261331.4
160 schema:familyName Hoyt
161 schema:givenName Dale G
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242743756.91
163 rdf:type schema:Person
164 sg:person.01362107006.03 schema:affiliation grid-institutes:grid.261331.4
165 schema:familyName Liu
166 schema:givenName Tongzheng
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362107006.03
168 rdf:type schema:Person
169 sg:person.0640400712.03 schema:affiliation grid-institutes:grid.261331.4
170 schema:familyName Shah
171 schema:givenName Vaibhav
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640400712.03
173 rdf:type schema:Person
174 sg:person.0701766503.35 schema:affiliation grid-institutes:grid.261331.4
175 schema:familyName Keshvara
176 schema:givenName Lakhu
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701766503.35
178 rdf:type schema:Person
179 sg:person.0752121645.38 schema:affiliation grid-institutes:grid.267313.2
180 schema:familyName Huang
181 schema:givenName Yongcheng
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752121645.38
183 rdf:type schema:Person
184 sg:pub.10.1007/s11259-007-9001-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053416274
185 https://doi.org/10.1007/s11259-007-9001-2
186 rdf:type schema:CreativeWork
187 sg:pub.10.1038/ncb0901-793 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006140773
188 https://doi.org/10.1038/ncb0901-793
189 rdf:type schema:CreativeWork
190 sg:pub.10.1038/nrm2261 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043505520
191 https://doi.org/10.1038/nrm2261
192 rdf:type schema:CreativeWork
193 sg:pub.10.1186/1476-9255-4-22 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037556817
194 https://doi.org/10.1186/1476-9255-4-22
195 rdf:type schema:CreativeWork
196 sg:pub.10.1290/1543-706x(2003)039<0043:aenmfi>2.0.co;2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011407638
197 https://doi.org/10.1290/1543-706x(2003)039<0043:aenmfi>2.0.co;2
198 rdf:type schema:CreativeWork
199 grid-institutes:grid.261331.4 schema:alternateName Division of Pharmacology, The Ohio State University College of Pharmacy, and The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, Ohio, USA
200 schema:name Division of Pharmacology, The Ohio State University College of Pharmacy, and The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, Ohio, USA
201 rdf:type schema:Organization
202 grid-institutes:grid.267313.2 schema:alternateName Department of Molecular Genetics, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, 75390, Dallas, Texas, USA
203 schema:name Department of Molecular Genetics, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, 75390, Dallas, Texas, USA
204 Division of Pharmacology, The Ohio State University College of Pharmacy, and The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, Ohio, USA
205 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...